Fundraising FoxTheravance Biopharma
1 known investors
Find your way into Theravance Biopharma
Sign up to see every warm intro you have to Theravance Biopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Theravance Biopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.
Founders & leadership
RF
Rhonda F. FarnumSenior Vice President, Commercial and Medical Affairs and Chief Business OfficerRhonda F. Farnum has held senior commercial and medical leadership roles across biotech and pharmaceutical companies, with expertise in product launches and commercialization in oncology, hematology, respiratory, and neurology. She serves as Senior Vice President of Commercial and Medical Affairs and Chief Business Officer at Theravance Biopharma.
SK
Stuart KnightSenior Vice President, IT&I and Chief Information Officer
AM
Aine MillerSenior Vice President, Development and Head of Ireland Office
AS
Aziz SawafChief Financial Officer and Senior Vice President of Operations Strategy
Investors · 1
Founder mafia
5 people who came through Theravance Biopharma went on to found or lead other companies.
Kevin JudiceVice President, ChemistryFounded DiCE Molecules +2Mathai MammenSenior Vice President, R&DFounded Fogpharma +1Jeffrey FinerVice President, Molecular & Cellular BiologyFounded SepternaMackenzie DrazanLab AssistantFounded MiResourceSamantha Miller 🌱Senior Director, Licensing/BD and Development Program LeaderFounded Cadence Health Liberate the Pill
Frequently asked questions
- What does Theravance Biopharma do?
- Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.
- Who are Theravance Biopharma's investors?
- Theravance Biopharma's investors include HEALTHCARE ROYALTY PARTNERS.